FDA Enforcement Class II Ongoing

Randox RX Series Urea Enzymatic Kinetic Assay Ref. Numbers: (1) UR3825 (2) UR3873 (3) UR8334 (4) UR8070 (Modena)

Recall: Z-2362-2023 · Reported August 16, 2023

Enforcement

Recall Number
Z-2362-2023
Event ID
92650
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Randox Laboratories Ltd.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
E-Mail
Report Date
August 16, 2023
Initiation Date
June 13, 2023
Classification Date
August 9, 2023
Address
55 Diamond Road, N/A, Crumlin (North), N/A, N/A, Ireland

Description

Randox RX Series Urea Enzymatic Kinetic Assay Ref. Numbers: (1) UR3825 (2) UR3873 (3) UR8334 (4) UR8070 (Modena)

Reason

Carryover from the Direct LDL-cholesterol assay on the Rx instruments may result in a negative bias, up to -11%, in quality control and patient samples, in urea assays results if the urea assay is run immediately after the Direct LDL-cholesterol assay. This may lead to a delay in reporting results or in falsely decreased urea test results.

Code Info

Catalogue Number/GTIN (1) UR3825 05055273206906; (2) UR3873 05055273206913 ; (3) UR8334 05055273209600; (4) UR8070 05055273209594. Not Batch Specific.

Distribution

US Nationwide distribution in the states of CA, DC, GA, OH, OK, MN, MO, NJ, VA and Puerto Rico.

Quantity

37 US 194 PR